Health ❯ Healthcare

Medical Treatments

Cancer Treatments Gene Therapy Oncology Pharmaceuticals Neurology Immunotherapy Alzheimer's Disease Weight Loss Surgery Pharmacology Diabetes Stem Cell Therapy Surgical Procedures Genetic Disorders Cosmetic Procedures Hormone Replacement Therapy Hyperbaric Oxygen Therapy Hormone Therapy Cardiology Neurological Disorders Cancer Treatment Transgender Health Obesity Treatments Cannabis Antibiotic Therapy Rare Diseases Radiation Therapy Oxygen Therapy Pain Management Biotechnology Cardiovascular Health Dialysis Infectious Diseases Antibiotics Aesthetic Treatments Ophthalmology Hormonal Treatments Cell Therapy Hospitalization Diabetes Management Thrombolysis Sleep Disorders Allergic Reactions Migraine Treatments Clinical Trials Pharmacotherapy In Vitro Fertilization FDA Approvals Hyperbaric Therapy Prescription Medications Dermatology Migraine Chemotherapy Biologics Obstructive Sleep Apnea Antimicrobial Treatments Drug Approvals Drug Delivery Cancer Therapies Cost of Healthcare Innovative Therapies Antibody Treatments Weight Loss Medications Eye Drops IV Drips Adeno-Associated Virus Device Withdrawals Obesity Treatment Reimbursement Policies Vitamin Therapy Thermal Ablation Wound Healing Intensive Care Cosmetic Surgery Sedation Respiratory Support Cancer Therapy Antidotes Injectable Medications Preventative Care Noninvasive Procedures Life-Saving Drugs Anticoagulants Therapeutic Proteins Gender Dysphoria Endocrine Therapy Self-Pay Services Hypertension Orthopedic Treatments Self-Pay Treatments Prostate Cancer Osteoarthritis Advanced Medical Technology Cannabis-based Products Diagnostic Imaging Cancer Care Fetal Medicine Focused Ultrasound Rehabilitation Antiplatelet Therapy

NICE Recommends Obe-cel CAR-T for Adult B-Cell ALL as NHS Readies Rollout Within Weeks

Fast-track NHS access follows trial evidence of high remission with reduced toxicity.

FDA Approves Durvalumab Added to Perioperative FLOT for Resectable Gastric and GEJ Cancer

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up

FDA Clears Padcev Plus Keytruda Regimens as Perioperative Option for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

FDA Approves Perioperative Keytruda–Padcev for Cisplatin‑Ineligible Muscle‑Invasive Bladder Cancer

New Zealand Pauses New Puberty Blocker Prescriptions for Gender Dysphoria

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

EMA Panel Backs Higher-Dose Spinraza for 5q SMA

FDA to Remove Most Boxed Warnings From Menopause Hormone Therapies

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

Hydrogen Sulfide Kills Drug-Resistant Nail Pathogens in Lab Tests

Veradermics Advances Long-Acting Oral Minoxidil Into Phase 3 U.S. Trials

NEJM Study Finds 95% Long-Term Success for ADA-SCID Gene Therapy

FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of High‑Risk CSCC

Survey Finds Life-Saving Role of Plasma Widely Recognized, Yet Donations Lag

Datroway Extends Survival Over Chemotherapy in First-Line TNBC Ineligible for Immunotherapy

Long-Term ASAP Trial Finds Disease Risk, Not Remission, Drives AML Transplant Survival

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC

Cannabis Stocks Jump After Trump Reposts Pro-CBD Video